T1	Intervention 0 47	Low-dose oral etoposide-based induction regimen
T2	Intervention 164 182	low-dose etoposide
T3	Intervention 338 382	epipodophyllotoxins during frontline therapy
T4	Intervention 384 541	In the first week of remission induction therapy, patients received etoposide (50 mg/m(2) per day) administered orally as a single agent once or twice daily.
T5	Intervention 542 626	On Day 8, patients started to receive dexamethasone, vincristine, and L-asparaginase
T6	Intervention 628 667	Etoposide was administered until Day 22
